Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ferric Carboxymaltose With or Without Phosphate Substitution for the Treatment of Iron Deficiency or Iron Deficiency Anemia Before Elective Surgery - the DeFICIT Trial

NCT05098249 is registered in ClinicalTrials.gov with Donat R. Spahn as lead sponsor.

NCT NCT05098249
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05098249 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ferric Carboxymaltose With or Without Phosphate Substitution for the Treatment of Iron Deficiency or Iron Deficiency Anemia Before Elective Surgery - the DeFICIT Trial
Lead sponsor
Donat R. Spahn
Phase
Phase 4
Overall status
Completed
Start date
November 11, 2021
Completion date
May 23, 2023
Enrollment
92 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, hypophosphatemia, iron-deficiency